TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7829769

Group type: EXPERIMENTAL
Intervention: Intravenous L-tryptophan (TRP)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Matched healthy controls
Number of subjects: 32
Study: 3341324

Group type: EXPERIMENTAL
Intervention: Lateral positioning (right and left)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Supine positioning
Number of subjects: 18
Study: 31385031

Group type: EXPERIMENTAL
Intervention: Differential outcomes procedure (DOP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-differential outcomes procedure (NOP)
Number of subjects: 0
Study: 31427312

Group type: EXPERIMENTAL
Intervention: DDI alerts implemented in EMM system
Number of subjects: 3360

Group type: COMPARATOR
Intervention: EMM system without DDI alerts
Number of subjects: 3360
Study: 27875061

Group type: EXPERIMENTAL
Intervention: Glycemic control target of 140 mg/dL
Number of subjects: 164

Group type: COMPARATOR
Intervention: Glycemic control target of 180 mg/dL
Number of subjects: 164
Study: 25522919

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided corticosteroid injection (1 ml containing 40 mg methylprednisolone acetate and 10 mg lidocaine hydrochloride)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided corticosteroid injection
Number of subjects: 55
Study: 24022261

Group type: EXPERIMENTAL
Intervention: Once-weekly iron supplements (200 mg ferrous sulphate containing 63 mg of elemental iron) for 24 weeks
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Twice-weekly iron supplements (200 mg ferrous sulphate containing 63 mg of elemental iron) for 12 weeks
Number of subjects: 352

Group type: COMPARATOR
Intervention: No iron supplements
Number of subjects: 352
Study: 21375099

Group type: EXPERIMENTAL
Intervention: Group N (negative words)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Group P (positive words)
Number of subjects: 232
Study: 18094675

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 1513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513
Study: 17312588

Group type: EXPERIMENTAL
Intervention: Zirconia femoral heads
Number of subjects: 60

Group type: COMPARATOR
Intervention: Co-Cr-Mo femoral heads
Number of subjects: 60
Study: 12943123

Group type: COMPARATOR
Intervention: Splint for less than 6 hours per day
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Splint for 6 to 12 hours per day
Number of subjects: 43
Study: 10698828

Group type: EXPERIMENTAL
Intervention: Phenytoin plus haloperidol
Number of subjects: 39

Group type: COMPARATOR
Intervention: Haloperidol plus placebo
Number of subjects: 39
Study: 9068511

Group type: EXPERIMENTAL
Intervention: Angiography after treatment with thrombolytics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regional death rate due to stroke
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall cardiovascular death rates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simple linear regression analysis
Number of subjects: 0
Study: 7513437

Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg/die
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg/die
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (first year), then Finasteride 5 mg/die (second year)
Number of subjects: 34
Study: 3092893

Group type: EXPERIMENTAL
Intervention: ethinyl oestradiol combined with polyoestradiol phosphate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: estramustine phosphate
Number of subjects: 30

Group type: COMPARATOR
Intervention: bilateral orchiectomy
Number of subjects: 30
Study: 30206095

Group type: EXPERIMENTAL
Intervention: Singing for people with aphasia (SPA) intervention - 10 group sessions plus a resource booklet
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control - resource booklet only
Number of subjects: 48
Study: 25808116

Group type: EXPERIMENTAL
Intervention: 10 g/day of milled flaxseed
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 30 g/day of milled flaxseed
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: All flaxseed doses
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 40 g/day of milled flaxseed
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: All doses
Number of subjects: 34
Study: 24906040

Group type: EXPERIMENTAL
Intervention: RG1068-stimulated MRCP
Number of subjects: 258

Group type: COMPARATOR
Intervention: MRCP
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: RG1068
Number of subjects: 258

Group type: COMPARATOR
Intervention: ERCP
Number of subjects: 258
Study: 22327109

Group type: EXPERIMENTAL
Intervention: Subpleural analgesia
Number of subjects: 42

Group type: COMPARATOR
Intervention: Thoracic epidural analgesia
Number of subjects: 42
Study: 20816030

Group type: EXPERIMENTAL
Intervention: Clinical trial participants with ADHD
Number of subjects: 393

Group type: COMPARATOR
Intervention: Community sample adults with ADHD
Number of subjects: 393

Group type: COMPARATOR
Intervention: Excluded community sample adults with ADHD
Number of subjects: 393
Study: 18528796

Group type: EXPERIMENTAL
Intervention: Telemetric group (with further telemonitoring support)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (without contact to clinic)
Number of subjects: 200
Study: 16042224

Group type: EXPERIMENTAL
Intervention: IFNbeta‐1a (Avonex) once weekly
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: IFNbeta three times weekly (Rebif and Betaferon)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (Copaxone)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Overall treatment with immunomodulatory drugs (IDs)
Number of subjects: 76
Study: 12183255

Group type: EXPERIMENTAL
Intervention: 1263W94 (100, 200, or 400 mg three times a day, or 600, 900, or 1,200 mg twice a day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10624380

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg, three times daily for 24 weeks
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo capsules, three times daily for 24 weeks
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 119
Study: 7670587

Group type: EXPERIMENTAL
Intervention: Pump cavernosometry (criterion I)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Pharmaco‐cavernosometry (criterion II)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: All four tests (criteria I)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: All four tests (criteria II)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Sequence of tests
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Pump cavernosometry, pharmaco‐cavernosometry, gravity cavernosometry, intracavernous pressure drop test
Number of subjects: 123
Study: 2258339

Group type: EXPERIMENTAL
Intervention: Pefloxacin (400 mg, iv, 8-hourly) for 5-30 days
Number of subjects: 71

Group type: COMPARATOR
Intervention: Imipenem (1 g, iv, 8-hourly) for 5-30 days
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Pefloxacin
Number of subjects: 71

Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 71
Study: 233177

Group type: EXPERIMENTAL
Intervention: Clostridium Welchii Type C antitoxin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31959342

Group type: COMPARATOR
Intervention: Standard-dose radium-223 (55 kBq/kg every 4 weeks for six cycles)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: High-dose radium-223 (88 kBq/kg every 4 weeks for six cycles)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Extended-schedule radium-223 (55 kBq/kg every 4 weeks for 12 cycles)
Number of subjects: 391

Group type: COMPARATOR
Intervention: High-dose vs Standard-dose
Number of subjects: 391

Group type: COMPARATOR
Intervention: Extended-schedule vs Standard-schedule
Number of subjects: 391

Group type: COMPARATOR
Intervention: Standard-dose radium-223
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: High-dose radium-223
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Extended-schedule radium-223
Number of subjects: 391
Study: 31204818

Group type: EXPERIMENTAL
Intervention: Parent-Web Internet-based parenting program
Number of subjects: 75

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 75
Study: 28403383

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Nicotine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Nicotine and Varenicline
Number of subjects: 44

Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 44
Study: 25840436

Group type: EXPERIMENTAL
Intervention: Healthy relationships program for eighth graders (adapted from the Fourth R program for ninth graders)
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1012
Study: 23891275

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30mg daily
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Metformin 1000mg daily
Number of subjects: 129
Study: 21349878

Group type: EXPERIMENTAL
Intervention: US and CD-guided mini-surgery (scraping) outside the ventral tendon
Number of subjects: 103

Group type: COMPARATOR
Intervention: Open treatment with a scalpel
Number of subjects: 103

Group type: COMPARATOR
Intervention: Percutaneous treatment with a needle
Number of subjects: 103
Study: 18787997

Group type: EXPERIMENTAL
Intervention: Activated Charcoal (AC) at 1 hour after ingestion
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Activated Charcoal (AC) at 2 hours after ingestion
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Activated Charcoal (AC) at 3 hours after ingestion
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no AC)
Number of subjects: 9
Study: 17715118

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 900 mg injection 1 hour before and immediately after contrast medium injection, plus hydration
Number of subjects: 87

Group type: COMPARATOR
Intervention: Hydration only
Number of subjects: 87
Study: 15049961

Group type: EXPERIMENTAL
Intervention: DHEA (50 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 10
Study: 12612144

Group type: EXPERIMENTAL
Intervention: Campbell's Condensed Tomato Soup (CS) - 35 +/- 1 mg lycopene/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Campbell's Ready To Serve Tomato Soup (RTS) - 23 +/- 1 mg lycopene/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: V8 Vegetable Juice (V8) - 25 +/- 1 mg lycopene/d
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups during washout period
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups after treatment
Number of subjects: 60
Study: 10373348

Group type: EXPERIMENTAL
Intervention: Low-dose recombinant human insulin-like growth factor-I (rhIGF-I; 1.5 microg/kg/h)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: High-dose recombinant human insulin-like growth factor-I (rhIGF-I; 9.0 microg/kg/h)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 5
Study: 7673863

Group type: EXPERIMENTAL
Intervention: Mood matching at encoding and retrieval (Experiment 3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mood differing at encoding and retrieval (Experiments 1 and 2)
Number of subjects: 0
Study: 2405140

Group type: EXPERIMENTAL
Intervention: Acute Illness Observation Scales (AIOS) teaching film and booklet
Number of subjects: 369

Group type: COMPARATOR
Intervention: 3-point global scoring system (Control)
Number of subjects: 369
Study: 6770399

Group type: EXPERIMENTAL
Intervention: Oral methadone (up to 10 mg)
Number of subjects: 0
Study: 31735137

Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 4181

Group type: EXPERIMENTAL
Intervention: Shunting
Number of subjects: 4181

Group type: EXPERIMENTAL
Intervention: Contralateral high-grade carotid stenosis or occlusion
Number of subjects: 4181

Group type: EXPERIMENTAL
Intervention: More severe neurological deficit (mRS, 3-5 versus 0-2)
Number of subjects: 4181
Study: 27995731

Group type: EXPERIMENTAL
Intervention: Insulin isophane
Number of subjects: 50

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both regimens after 3 days
Number of subjects: 50
Study: 27070903

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (1010 cfu per day) for three weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 24612448

Group type: EXPERIMENTAL
Intervention: Eyesi cataract simulator training programme (Group A) - completed once a week for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (Group B) - completed training once a week at the first and last week
Number of subjects: 20
Study: 22277556

Group type: EXPERIMENTAL
Intervention: Riboflavin (1.6 mg/d for 16 wk)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 19281446

Group type: EXPERIMENTAL
Intervention: Normal Level of Replacement Therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Augmented Level of Replacement Therapy
Number of subjects: 0
Study: 17685917

Group type: EXPERIMENTAL
Intervention: Prophylaxis with routine infusions of factor VIII (FVIII) concentrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: On-demand FVIII treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Escalating dose frequency of prophylaxis
Number of subjects: 0
Study: 15937369

Group type: EXPERIMENTAL
Intervention: North Indian diet (high calorie, high fat)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: South Indian diet (low calorie, low fat)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 9
Study: 12184540

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPI)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 9641318

Group type: EXPERIMENTAL
Intervention: Spontaneous otoacoustic emissions (SOAEs) measured by placing a small microphone at the entrance to the ear canal, analyzed acoustically with external tones.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External tones presented as 250 ms pulses, twice a second.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consumption of aspirin by one subject.
Number of subjects: 0
Study: 8086551

Group type: EXPERIMENTAL
Intervention: iv clindamycin (900 mg every 8 hours for 10 days, then oral clindamycin (450 mg every 6 hours for 11 days) + oral primaquine (30 mg once daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: oral clindamycin (600 mg every 8 hours) + oral primaquine (30 mg once daily)
Number of subjects: 60
Study: 31857511

Group type: EXPERIMENTAL
Intervention: SVV-guided fluid therapy (group S)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 120
Study: 27598342

Group type: EXPERIMENTAL
Intervention: Local muscle vibration treatment (300 Hz, 30 minutes, 3 times per week for 12 sessions)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 32
Study: 27571294

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Light touch (LT)
Number of subjects: 387

Group type: COMPARATOR
Intervention: Conventional care only (CCO)
Number of subjects: 387
Study: 24960439

Group type: EXPERIMENTAL
Intervention: Unified Protocol for the Treatment of Emotional Disorders in Adolescence (UP-A)
Number of subjects: 59
Study: 22295884

Group type: EXPERIMENTAL
Intervention: Drotaverine hydrochloride (80 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Diclofenac sodium (75 mg)
Number of subjects: 100
Study: 19856067

Group type: EXPERIMENTAL
Intervention: Oral levofloxacin 500 mg once daily
Number of subjects: 164
Study: 17084792

Group type: EXPERIMENTAL
Intervention: Methadone medical maintenance (MMM) at the methadone maintenance program
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Methadone medical maintenance (MMM) at a physician's office
Number of subjects: 92

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 92
Study: 15574068

Group type: EXPERIMENTAL
Intervention: Multiple-set resistance training
Number of subjects: 71

Group type: COMPARATOR
Intervention: Single-set resistance training
Number of subjects: 71
Study: 14728019

Group type: EXPERIMENTAL
Intervention: Transfer for primary angioplasty without fibrinolytic treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early aggressive approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre-hospital ambulance triage to interventional centers
Number of subjects: 0
Study: 9236500

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray 50 micrograms
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray 100 micrograms
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray 200 micrograms
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray 800 micrograms
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo vehicle
Number of subjects: 480
Study: 8422174

Group type: COMPARATOR
Intervention: Group C: 12 mg/m2 of MMC on the day of operation, followed by 6 mg/m2 every 2 months for 6 times, and 600 mg/body of UFT continuously administered every day for 1 year.
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Group D: 400 mg/body of UFT every day and the same amount of MMC as Group C.
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: UFT dosage per body weight (kg) of 8-12 mg/kg.
Number of subjects: 556
Study: 2446056

Group type: EXPERIMENTAL
Intervention: Ketanserin (40 mg b.i.d. after 2 weeks of 20 mg b.i.d.)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Nifedipine (20 mg N retard b.i.d.)
Number of subjects: 117
Study: 30566439

Group type: EXPERIMENTAL
Intervention: Linear projection method for gene expression data
Number of subjects: 3571

Group type: EXPERIMENTAL
Intervention: Projection coordinates as covariates in eQTL analysis
Number of subjects: 3571
Study: 27488574

Group type: EXPERIMENTAL
Intervention: AMP XR-ODT (18.8 mg)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: AMP XR-ODT (18.8 mg) with food
Number of subjects: 42

Group type: COMPARATOR
Intervention: MAS ER (30 mg)
Number of subjects: 42
Study: 25376790

Group type: EXPERIMENTAL
Intervention: Apatinib 500 mg daily on days 1 through 28 of each 4-week cycle
Number of subjects: 38
Study: 23760573

Group type: EXPERIMENTAL
Intervention: Tagatose (5 g)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Tagatose (10 g)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Sucralose-erythritol drink (placebo)
Number of subjects: 85
Study: 20806849

Group type: EXPERIMENTAL
Intervention: Time management training
Number of subjects: 71

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 71
Study: 18213452

Group type: EXPERIMENTAL
Intervention: Simvastatin delayed release tablet (20 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simvastatin immediate release capsule (20 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simvastatin immediate release tablet Zocor (20 mg)
Number of subjects: 0
Study: 15760500

Group type: EXPERIMENTAL
Intervention: Warmed (35 degrees C) and humidified (95%) CO2
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard (dry, room temperature) CO2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Postoperative pain scores and narcotic usage
Number of subjects: 30
Study: 12612979

Group type: EXPERIMENTAL
Intervention: Atorvastatin in addition to ACE inhibitors and ARBs
Number of subjects: 56

Group type: COMPARATOR
Intervention: No atorvastatin in addition to ACE inhibitors and ARBs
Number of subjects: 56
Study: 10697305

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 16 mg once daily for 6 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 8612120

Group type: EXPERIMENTAL
Intervention: 10 mg of astemizole
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: 5 mg of cetirizine
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: 10 mg of cetirizine
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control group (astemizole)
Number of subjects: 263
Study: 2017020

Group type: EXPERIMENTAL
Intervention: Activation force of 20 N
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Activation force of 50 N
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Activation force of 100 N
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Angular velocity of 45 degrees.s-1
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Angular velocity of 135 degrees.s-1
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Concentric muscle actions at 80 degrees knee flexion
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Eccentric muscle actions at 20 degrees flexion
Number of subjects: 24
Study: 10250813

Group type: EXPERIMENTAL
Intervention: Individual Management Plan (IMP)
Number of subjects: 432
Study: 29117764

Group type: EXPERIMENTAL
Intervention: LAM + EC (counseling and in advance provision of one packet of 0.75‐mg LNG‐ECPs)
Number of subjects: 2708

Group type: COMPARATOR
Intervention: LAM-only (adequate lactational amenorrhea method counseling)
Number of subjects: 2708
Study: 29176387

Group type: EXPERIMENTAL
Intervention: CODJ-G (complex COD and plyometric protocol)
Number of subjects: 21

Group type: COMPARATOR
Intervention: COD-G (isolated COD protocol)
Number of subjects: 21
Study: 27569118

Group type: EXPERIMENTAL
Intervention: Zero-calorie alternate-day fasting (ADF)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Moderate daily caloric restriction (CR)
Number of subjects: 26
Study: 25040146

Group type: EXPERIMENTAL
Intervention: 50% reduction of angiotensin inhibitor dose (n=30)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard basal dose of angiotensin inhibitors (n=16)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 46
Study: 23074122

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol
Number of subjects: 62

Group type: COMPARATOR
Intervention: Balanced anesthesia with desflurane
Number of subjects: 62
Study: 20706157

Group type: EXPERIMENTAL
Intervention: Plyometric (PL) training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Olympic weight lifting (OL) training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combined weight lifting + plyometric (WP) training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (C) group
Number of subjects: 36
Study: 17126339

Group type: EXPERIMENTAL
Intervention: r‐LH (150 IU per day from day 8 of gonadotropin stimulation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (r‐FSH alone)
Number of subjects: 40